Media releases are provided as is by companies and have not been edited or checked for accuracy. Any queries should be directed to the company itself.
  • 12 June 2019 22:01

According To Research, The Coronary Stent Market Is Projected To Reach A Value Of Over Us$ 11,431.3 Mn In 2027

Coronary Stent Market By Product Type (Drug-Eluting Stent, Bare-Metal Stent, And Others), By Material Type (Metallic And Others), By End User (Hospitals, Cardiac Center, And Others), And Region - Growth Forecast To 2027


Coronary angioplasty is a medical procedure used to treat coronary heart diseases. A small balloon is inflated inside one or more coronary arteries in order to open an area of arteries become narrow to improve blood flow to patients’ heart. The global Coronary Stent Market is estimated to be valued at approximately US$ 6,619.7 Mn in 2019, and is expected to register a CAGR of over 6.8%.

Global Coronary Stent Market Dynamics:

Increasing incidence and prevalence of cardiovascular, and lifestyle diseases, coupled with increasing aging population, and rising demand for treatment of various cardiovascular diseases and conditions is expected to result in growing patient pool and hospitalization, which is expected to drive growth of the global coronary stent market over the forecast period. According to WHO - CVDs are the leading cause of death globally. Owing to increasing incidence of cardiovascular diseases, more people die annually as compared to other causes or diseases. In 2016, approximately 17.9 Mn people died from CVDs, represented 31.0% of all global deaths. Among these deaths, around 85.0% are due to heart attack and stroke. In US, coronary heart disease accounts for 1 in 7 deaths in 2015, killed over 366,800 people in a year.

In addition, innovative product launches and technological advancements in coronary stent market are some other factors expected to further fuel growth of the target market over the forecast period. For instance, in February 2018, Medtronic plc. launched Resolute Onyx 2.0 mm Drug-Eluting Stent (DES) - the smallest sized DES in the US market. The new stent is intended to help interventional cardiologists treat patients with coronary artery disease (CAD) who have small vessels often untreatable with larger stent technologies during percutaneous coronary intervention (PCI). Additionally, in September 2018, Terumo Corporation launched the Ultimaster and Tansei drug eluting stent (DES) in Japan. Terumo has already launched the product in Europe in May, and will expand its DES sales coverage to other areas.

Analysis By Segmentation:

The market report has been segmented on the basis of product type, material type, end user, and region. The product type segment includes drug-eluting stent, bare-metal stent, and bioresorbable vascular stent. The material type segment includes metallic (Cobalt Chromium (CoCr), Platinum Chromium (Pt-Cr), Stainless Steel, and Nickel Titanium) and others.

The end user segment includes hospitals, cardiac center, and others. The regions covered in the analysis includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

By Product Type: The drug-eluting stent segment accounted for highest revenue share contribution as compared to other type segment, and is expected to register a CAGR of over 6.8% between 2018 and 2027.

By material Type: The metallic segment accounted for highest revenue share contribution as compared to other material type segment, and is expected to register a CAGR of over 6.6% between 2019 and 2027.

By end user: The hospitals segment accounted for highest revenue share contribution as compared to other end user segment, and is expected to register a CAGR of over 6.6% between 2019 and 2027.

By Region: The market in North America accounted for highest revenue share in the global coronary stent market in 2018, and is expected to register a CAGR of over 6.5% between 2019 and 2027.

Global Coronary Stent Market: Competitive Analysis

The research report on the global coronary stent market include profiles of some of major companies such Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, TERUMO CORPORATION, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Vascular Concepts, Translumina GmbH.

The Global Coronary Stent Market: Global Industry, Size, Share, Growth, Trends, and Forecast, 2017–2026 report has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the present scenario and the growth prospects of the global Coronary Stent market for 2017–2028.

About Us: is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.

Contact Us:

Lawrence John

420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Email ID:

Tel: +1 347 826 1876


Submit a media release